CTRI/2021/07/035172Not yet recruiting未知
Comparing the efficacy of Aprepitant Vs Ondansetron for the prevention of post-operative nausea vomiting (PONV) in patients undergoing posterior fossa craniotomy for excision of tumour causing brainstem compression â?? A double blind randomised controlled Trial.
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Christian Medical College
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •All patients aged between 18-70 years, ASA grade I-III undergoing posterior fossa craniotomy for excision of tumour.
Exclusion Criteria
- •1. Extremes of age < 18 and > 70 years
- •3. Patients with known allergies to the drugs being used
- •4. Patients with QT prolongation (Corrected QTc > 440 sec)
- •5. Patients with planned/ unplanned postoperative ventilation
- •6. Patients who are on NG tube or who need NG tube placement post-surgery
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Comparing response of Aprepitant and Ondansetron with only Aprepitant in Post operative nausea and vomiting in craniotomy patients.CTRI/2021/04/032588DEPARTMENT OF ANAESTHESIOLOGY AND CRITICAL CARE JNMC ALIGARH MUSLIM UNIVERSITY
Completed
Phase 3
The effect of Ondansetron in combination with Apotel in pain controlPatients with upper limb fractures..IRCT2017062133566N1Vice chancellor for research, Golestan University of Medical Sciences50
Completed
Phase 4
To compare the effect of two drugs ondansetron and aprepitant in preventing nausea and vomiting after surgery in patients undergoing thyroid or breast operationsCTRI/2017/07/009107Christian medical college125
Completed
Phase 3
Comparison of Effectiveness of Ondansetron versus Metoclopramide in Hyperemesis GravidarumIRCT20190528043735N1Zanjan University of Medical Sciences154
Recruiting
Phase 4
between palonosetron and aprepitant which one is better in preventing nausea and vomiting in females undergoing laparoscopic surgeryCTRI/2021/01/030613VIMSAR
